Skip to Content

WATSON 617 (Morphine Sulfate Extended Release 100 mg)

Pill with imprint WATSON 617 is Gray, Round and has been identified as Morphine Sulfate Extended Release 100 mg. It is supplied by Watson Laboratories, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 617

Morphine sulfate extended release 100 mg WATSON 617

Morphine Sulfate Extended Release

Imprint
WATSON 617
Strength
100 mg
Color
Gray
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-0617

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.